Icosavax, Inc.
Biotechnology company · Seattle, Washington, United States
Icosavax, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $100 million sold in a notice filed in 2021.
Icosavax at a glance
What does Icosavax do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $99.7 million sold (2021).
Frequently asked questions about Icosavax
Where is Icosavax headquartered?
Icosavax, Inc. is headquartered in Seattle, Washington, United States.
What does Icosavax do?
Icosavax, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Icosavax founded?
The earliest incorporation on record for Icosavax, Inc. is in 2017, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences